Clinical Trials Browser

Phase 3 × 5-aminolevulinic acid hexyl ester × 1 year × Clear all

NCT06525571 2025-11-18

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Phase 3 Recruiting

Urinary Bladder Neoplasms